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Abstract: The need for novel antibiotics comes from the relatively high incidence of   bacterial 
infection and the growing resistance of bacteria to conventional antibiotics. Consequently, 
new methods for reducing bacteria activity (and associated infections) are badly needed. 
Nanotechnology, the use of materials with dimensions on the atomic or molecular scale, has 
become increasingly utilized for medical applications and is of great interest as an approach to 
killing or reducing the activity of numerous microorganisms. While some natural antibacterial 
materials, such as zinc and silver, possess greater antibacterial properties as particle size is 
reduced into the nanometer regime (due to the increased surface to volume ratio of a given mass 
of particles), the physical structure of a nanoparticle itself and the way in which it interacts with 
and penetrates into bacteria appears to also provide unique bactericidal mechanisms. A variety 
of techniques to evaluate bacteria viability, each with unique advantages and disadvantages, has 
been established and must be understood in order to determine the effectiveness of nanoparticles 
(diameter #100 nm) as antimicrobial agents. In addition to addressing those techniques, 
a review of select literature and a summary of bacteriostatic and bactericidal mechanisms are 
covered in this manuscript.
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The need for novel antibiotics
In recent years, the number of infections associated with antibiotic-resistant bacteria 
has increased. The Center for Disease Control and Prevention reports that the number 
of annual multidrug-resistant Staphylococcus aureus (MRSA) infections increased 
from 127,000 to 278,000 between the years 1999 and 2005. Similarly, the number 
of annual MRSA-related deaths increased from 11,000 to 17,000 over the same time 
frame. While a decline in the prevalence of MRSA infections was reported from 2005 
to 2008 due to the implementation of preventative measures,1 these infections remain a 
concern. The rise of MRSA is attributed primarily to the overuse and improper use of 
antibiotics. Bacteria, with their large populations and fast reproduction time, are able 
to rapidly develop mechanisms of antibiotic resistance when a subset of the bacteria 
population survives antibiotic exposure. Antibiotic resistance may develop via multiple 
mechanisms. Briefly, the primary mechanisms include alteration or inactivation of 
the antibiotic by the bacteria, alteration of the target site of the antibiotic, alteration 
of a metabolic pathway to avoid the disruptive effect of the antibiotic, and reduced 
accumulation of the drug by minimizing its entry or maximizing   clearance from 
the cell. To illustrate one such mechanism, inactivation of the antibiotic, antibiotic 
resistance may be due to the ability of the bacteria to adapt production of beta-lactamase International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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enzymes which cleave the beta-lactam ring, neutralizing 
beta-lactam antibiotics such as penicillin.   Bacteria, such as 
S. aureus, may use this mechanism alone, or in   conjunction 
with other   resistance mechanisms, to   dramatically reduce 
its susceptibility to the bactericidal effects of large classes 
of   traditional antibiotics. For this reason, entirely new 
approaches to antibiotic development are necessary to 
keep up with the constantly changing antibiotic resistance 
of   bacteria. Nanoparticles, which rely on entirely differ-
ent mechanisms of antibacterial activity than traditional 
antibiotics, provide a compelling alternative.
Assays to evaluate antibacterial 
activity
Determining the effectiveness of a nanoparticle as an 
antibacterial agent requires experimental techniques that 
measure bacteria viability after exposure. While numerous 
techniques have been developed to determine the antibacterial 
activity of nanoparticles, many of them are flawed in their 
own way. As a result, multiple techniques are often used in 
a single study to compare and confirm antibacterial results. 
Furthermore, Gram-positive and Gram-negative bacteria 
may respond to antibacterial nanoparticles differently and 
also assay differently. Therefore, studies often include at 
least one Gram-positive species and one Gram-negative 
species in a variety of assays to determine antibiotic efficacy. 
Due to the importance of developing novel antibacterial 
treatments, this paper will summarize current assays used for 
assessing in vitro bacteria activity, highlighting advantages 
and disadvantages of each assay (Table 1). The technique 
chosen for a study depends, in part, on the type of data 
needed. Bacteria plating is a technique that can be used to 
evaluate bacteria susceptibility to nanoparticles. This assay is 
a simple way to identify whether the experimental conditions 
produced an entirely antibacterial environment, and thus 
this assay determines minimum inhibitory concentrations 
(MIC) or minimum bactericidal concentrations (MBC). 
Other more sophisticated assays, including live/dead staining 
and tetrazolium salt reduction assays provide data related to 
specific percentages of bacteria viability in the presence of 
the antibacterial agent.
Optical density of cell suspensions
Cell density in a planktonic bacteria suspension is often 
estimated by measuring the optical density, or turbidity, of 
the cell suspension and correlating that optical density to cell 
concentration. Using this technique, the rate of proliferation 
can be estimated by measuring cell density across a range 
of time points. As bacteria proliferate in cell culture media, 
their cell bodies increasingly block light that passes through 
the sample. The optical density of samples of a standard 
volume (and associated light path length) can be measured 
with a spectrophotometer and compared to other samples. 
When less light is able to penetrate a sample, the density of 
bacteria in the sample is greater. While some studies report 
values from direct optical density measurements, others 
establish a standard curve so that experimental optical 
density values can be matched with cell density. This cell 
density is often established by serially diluting a bacteria cell 
suspension, measuring the optical density of the dilutions, 
and then spreading each sample onto an agar plate. After an 
appropriate incubation time, the bacteria colonies can be 
counted to more accurately determine the number of colony 
forming units (CFUs) present in each sample.
While the advantage of optical density measurements 
is its simplicity (no reagents or processing of the sample is 
required), one complication associated with using optical 
density techniques to determine bacteria viability in the 
presence of nanoparticles is that nanoparticles themselves 
contribute to the optical density of the sample. Like bacteria 
Table 1 Comparison of commonly-used methods of quantifying bacteria viability
Assay Advantages Disadvantages
Optical density measurement 
Cell counting devices
Quick, no reagents required 
High accuracy
Spectrophotometer required, low accuracy 
Costly device
Spread-plate (colony counts on agar) High accuracy Determines CFU count but not total cell population or 
size of CFUs, time consuming, large amounts of disposable 
materials required, cells must be removed from surfaces for 
measurement
Crystal violet staining Quantifies biofilm formation Spectrophotometer required, not suitable for planktonic 
bacteria growth
Live/dead fluorescent stain Allows visualization of sample surface Costly reagents, fluorescent plate reader or microscope required
MTS/MTT/XTT assays Measures cell viability on surfaces and  
in solution
Spectrophotometer required, costly reagents
Abbreviation: CFU, colony forming unit.International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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cell bodies, nanoparticles are also capable of scattering 
spectrophotometer light. To resolve this issue, authors of 
some studies have measured the optical densities of a standard 
curve of nanoparticles alone and then subtracted those values 
from the optical densities of the suspensions of a combina-
tion of cells and nanoparticles.2 However, the precision with 
which cell density can be measured with this technique, 
particularly at low cell densities, is questionable.
Cell counting instruments
Devices used to quantify the number of cells in a liquid 
suspension, including Coulter counters, can also be used to 
determine bacteria populations. A Coulter counter operates 
by drawing a cell suspension through a channel that separates 
two chambers of an electrolyte solution. Interference with 
the conductivity between two chambers of the electrolyte 
solution, due to the resistance of the cells, is detected and 
processed to determine cell density. The presence of cells (as 
well as other particles) and the size distribution of the cells 
(or size of a CFU of bacteria) can be determined.
In contrast to optical density measurements which do 
not provide information on the size of the cells and particles 
present, a Coulter counter provides more useable data. Issues 
related to nanoparticle interference with cell counting are 
avoided.
Spread-plate colony counts
Viable CFUs present after exposure to nanoparticles can also 
be determined by spreading bacteria suspensions on an agar 
plate. In the so called spread-plate technique, cell suspension 
samples are serially diluted and a small volume of sample 
is then spread across the surface of an agar plate (often with 
a Lazy-L Spreader™ [Sigma Aldrich Corp, St Louis, MO] 
or similar device). CFUs are counted after an incubation 
period. Taking the dilution process into consideration, 
  calculations are then performed to determine the cell   density 
in the original sample. When compared to plates spread 
from samples that did not contain nanoparticles, the percent 
reduction in viable CFUs can be determined.
A CFU counted on an agar plate may have arisen from 
a single bacterium or may have come from a larger cluster 
of many bacteria. Uncertainty in the experimental results 
can arise when an additive to a bacteria cell suspension that 
reduces the yield of CFUs may be killing a portion of the 
bacteria, or may only be causing the bacteria to flocculate. 
This uncertainty makes use of multiple techniques to confirm 
results additionally important. In some cases, low intensity 
ultrasound treatment may be used to disrupt bacteria clusters 
into individual cells, thus, increasing the number of CFUs 
and providing data that more accurately relates to the total 
number of viable cells present.
One critique of the accuracy of evaluating the antibacterial 
effect of nanoparticles in a liquid system is that as 
nanoparticles interact with intracellular components of lysed 
cells, nanoparticle agglomeration occurs and prevents 
nanoparticle interactions with still living cells.3 The 
incorporation of nanoparticles directly into a nutrient agar 
surface ensures exposure to the bacteria on the surface of 
the plate, but reduces complications associated with the 
nanoparticles being “thrown out” of the liquid system. 
In many studies, nanoparticles are incorporated directly 
into the agar plate rather than a liquid media suspension. 
A small volume of bacteria suspension is spread on the 
agar plate and incubated. CFUs are counted after suitable 
colony development. A reduced number of CFUs on an 
agar plate with incorporated nanoparticles indicates that the 
nanoparticles have an antibacterial effect.
Crystal violet staining
As a bacteria colony takes hold in a host, a biofilm may be 
formed. Crystal violet (hexamethyl pararosaniline chloride) 
can be used to evaluate the amount of biofilm formed by 
staining the thick peptidoglycan layer of Gram-positive 
bacteria, the thin peptidoglycan layer of Gram-negative 
bacteria, and components of the extracellular biofilm.4 
When exposed to a crystal violet stain solution, the amount 
of stain absorbed by the biofilm is generally proportional 
to the quantity of biofilm present. A standardized rinsing 
procedure can remove the unabsorbed staining solution, 
leaving behind only the staining solution absorbed by the 
biofilm itself. A solvent can then be used to remove the 
absorbed crystal violet, and the extent to which the solvent 
changes color due to the presence of the crystal violet stain 
can be measured with a spectrophotometer. This color change 
is proportional to the quantity of biofilm present. In this way, 
biofilm formation in the presence of nanoparticles can be 
compared to the control biofilm.
Live/dead staining
The use of live/dead cell viability assays offers an   additional 
and, arguably, more accurate representation of the presence 
of viable bacteria in solution or on a surface. The live/dead 
cell viability assay is a combination of two separate cell 
stains, one (Syto® 9 green fluorescent nucleic acid stain 
[Invitrogen Corporation, Carlsbad, CA], excitation 480 nm/
emission 500 nm) which stains all cells living or dead, and International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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one (propidium iodide, excitation 490 nm/emission 635 nm) 
which is only able to stain cells which have a compromised 
membrane and are, therefore, dead or dying. When used 
together, these dyes allow for the identification of both   living 
and dead cells in a single sample. Once cell staining is com-
plete, samples can be analyzed with a fluorescent plate reader 
or using fluorescence microscopy techniques. A   fluorescent 
plate reader quantifies emissions at the excitation wave-
lengths of each stain. The peaks produced by each stain are 
compared to determine the approximate quantities of live 
and dead cells, and also the ratio of live cells to dead cells. 
Alternatively, bacteria grown on a surface (generally in bio-
film form) can be analyzed using fluorescence microscopy 
techniques. The excitation wavelengths of the dyes are used 
to view both live and dead cells. This allows for visualiza-
tion of the cells on the surface. At higher magnifications 
($40×) individual bacteria are visible. For quantification, 
living and dead cells within the field of view can be counted. 
Confocal fluorescence microscopy can be used to collect 
three-dimensional data on the structure and thickness of the 
biofilm. However, for an accurate biofilm thickness estimate, 
sample surfaces must be very flat.
Tetrazolium salt reduction assays
A variety of assays estimate cell viability via the reduction 
of tetrazolium salts to formazan dyes. These assays 
are colorimetric, and the color change produced can 
be quantified with a spectrophotometer. MTT (3-[4,5-
  Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide), 
XTT (2,3-bis-[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetra-
zolium-5-carboxanilide), and MTS (3-[4,5-dimethylthiazol-
2-yl]-5-[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-
tetrazolium) assays are reduced to formazan in the presence 
of reductase enzymes produced by living cells. The amount 
of formazan dye produced is proportionate to the quantity 
of viable cells present. In other words, the difference in 
color change between experimental and control groups of a 
known cell   density can be attributed to the effectiveness of 
an antibacterial agent introduced to the experimental group. 
The amount of reductase enzyme produced by each cell is, 
however, related to metabolic activity. Cells with reduced 
metabolic activity, such as those in a biofilm, may produce 
a reduced amount of reductase enzyme, thus potentially 
producing artificially low cell numbers when viable cells are 
being quantified with this particular type of assay. Also, high 
densities of bacteria may produce the maximum amount of 
formazan product and the optical density of the sample may 
appear comparable to even greater cell densities.
Antibacterial nanoparticles
The antibacterial properties of a variety of nanostructures 
have been investigated. In understanding the antibacte-
rial properties of these nanostructures, it is important to 
recognize that while some metals, such as zinc, silver, and 
copper, exhibit antibacterial mechanisms in their bulk form, 
other materials, such as iron oxide, are not antibacterial in 
their bulk form but may exhibit antibacterial properties in 
nanoparticulate form.
The mechanism of this antibacterial activity varies from 
nanoparticle to nanoparticle. For all varieties of nanoparticles, 
the antibacterial mechanism is not fully understood. While 
some proposed mechanisms relate to the physical structure 
of the nanoparticles (ie, membrane-damaging abrasiveness 
of the nanoparticle), others relate to the enhanced release of 
antibacterial metal ions from nanoparticle   surfaces. The 
specific surface area of a dose of nanoparticles increases 
as the particle size decreases, allowing for greater mate-
rial interaction with the surrounding environment. Thus, 
for inherently antibacterial materials, such as zinc and 
silver, increasing the surface to volume ratio enhances the 
antibacterial effect. A nanoparticle of an inherently antibacte-
rial material may, therefore, have multiple mechanisms of 
antibacterial activity, such as the release of antibacterial metal 
ions from the particle surface and the antibacterial physical 
properties of a nanoparticle related to cell wall penetration 
or membrane damage.
Comparing results across a greater number of studies 
allows for the identification of nanoparticle parameters which 
are most relevant in designing the ideal antibacterial particle 
(Table 2). Chemistry, particle size, particle shape, and zeta 
potential are among the most relevant variables affecting 
antibacterial activity.
Zinc oxide (ZnO)
ZnO has been shown to naturally reduce the activity of a wide 
range of (mostly Gram-positive) bacteria strains without the 
use of antibiotics.5 Implementation of nanotechnology has 
further enhanced the antibacterial properties of ZnO.6–8
For example, a study that used particle supplements to 
liquid cell suspensions to investigate the antibacterial effect 
of both micronscale and nanoscale ZnO particles concluded 
that nanoparticles had a greater antibacterial effect.9 ZnO 
nanoparticles (average mean diameter = 60 nm, zeta poten-
tial under experimental conditions = −5 mV) and micron-
scale ZnO particles were added to bacteria suspensions at 
a   concentration of 20 µg/mL, incubated for 2 hours, and 
then added to agar plates in order to count viable colonies. International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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Table 2 Summary of select studies concerning the antimicrobial effects of nanoparticles
Chemistry Size  
(average)
Zeta  
potential
Organism  
tested
MIC Proposed  
mechanism
Reference
ZnO 13 nm N/A Staphylococcus  
aureus
Reduced 95% at 80 µg/mL ROS inhibition Reddy10
ZnO 60 nm N/A S. aureus Reduced 50% at 400 µg/mL ROS inhibition Jones2
ZnO 40 nm Positive  
(no value)
S. aureus,  
Escherichia coli
Both species reduced 99% at  
400 µg/mL
Membrane disruption Nair11
ZnO 12 nm N/A E. coli Reduced 90% at 400 µg/mL Membrane damage due  
to particle abrasiveness
Padmavathy12
ZnO ions N/A N/A Pseudomonas  
aeruginosa,  
S. aureus,  
Candida albicans
Reduced 100% at 1917, 9, and  
39 µg/mL, respectively
ROS inhibition McCarthy13
Silver 21 nm N/A E. coli,  
Vibrio cholerae,  
Salmonella typhi,  
P. aeruginosa
All reduced 100% at 75 µg/mL Membrane disruption,  
Ag ion interference  
with DNA replication
Morones18
Silver Triangles  
(50 nm)
Positive  
(no value,  
cationic surfactant)
E. coli Reduced 99% with 0.1 µg/mL  
added to agar surface
Membrane disruption,  
Ag ion interference  
with DNA replication
Pal20
Silver 12 nm Negative  
(no value)
E. coli Reduced 70% with 10 µg/mL  
in agar
Membrane disruption,  
Ag ion interference  
with DNA replication
Sondi3
Silver 13.5 nm −0.33 mv S. aureus,  
E. coli
Inhibitory concentration of  
3.56 µg/L and 0.356 µg/L,  
respectively, added to agar surface
Membrane disruption,  
Ag ion interference  
with DNA replication
Kim21
Cu 100 nm N/A E. coli,  
Bacillus subtilis
Reduced 90% at 33.40 µg/mL and 
28.20 µg/mL, respectively
Protein inactivation  
via thiol interaction
Yoon22
Fe3O4 9 nm −19.09 mv S. aureus Increased dead cells observed  
at 3 mg/mL
ROS, membrane  
disruption
Tran24
Fe3O4 8 nm N/A Staphylococcus  
epidermidis
Reduced 65% at 2 mg/mL ROS, membrane  
disruption
Taylor25
Al2O3 11 nm 120 mv E. coli Reduced 35%, 70%, and 68% at 10, 
100, and 500 µg/mL, respectively
Dose-dependent ROS,  
particle penetration
Simon- 
Deckers26
Al2O3 60 nm 30 mv E. coli,  
B. subtilis,  
Pseudomonas  
fluorescens
Reduced bacteria species by 36%, 
57%, and 70% at 20 µg/mL
Flocculation Jiang9
TiO2 17 nm 12 mv E. coli Reduced 0%, 35%, and 80% with  
10, 100, and 500 µg/mL, respectively
Membrane disruption Simon- 
Deckers26
SiO2 20 nm 35 mv E. coli,  
B. subtilis,  
P. fluorescens
Reduced bacteria species 58%,  
40%, and 70% at 20 µg/mL
Flocculation, membrane  
disruption
Jiang9
Chitosan 40 nm 51 mv E. coli,  
S. aureus
Reduced bacteria species 100% at  
4 µg/mL and 8 µg/mL, respectively
Flocculation, membrane  
disruption
Qi27
Abbreviations: Ag, silver; Al2O3, aluminum oxide; Cu, copper; Fe3O4, iron oxide; MIC, minimum inhibitory concentration; N/A, not available; ROS, reactive oxygen species; 
SiO2, silicon dioxide; TiO2, titanium dioxide; ZnO, zinc oxide.
While micron-size ZnO particles reduced colony counts 
of Bacillus subtilis, Escherichia coli, and Pseudomonas 
fluorescens by 100%, 75%, and 50%, respectively, ZnO 
nanoparticles reduced viability of all bacteria species by 
100% compared to controls. In both the micronscale and 
nanoparticle form, ZnO was more toxic to all bacteria spe-
cies than other comparably-sized particle chemistries tested 
(such as aluminum oxide and silicon dioxide).
Complete inhibition of planktonic S. aureus growth 
has been observed at ZnO nanoparticle (mean average 
diameter = 13 nm) concentrations of $1 mM (81.408 µg/mL) 
in overnight cultures.10 A 95% inhibition of S. aureus 
growth in the presence of 1 mM of 8 nm ZnO nanopar-
ticles after 10 hours and a 40%–50% inhibition of the 
same S. aureus in the presence of 5 mM (407.04 µg/mL) of 
50–70 nm ZnO nanoparticles after 10 hours was observed.2 International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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While highlighting the discrepancies in the antibacterial 
effect among ZnO nanoparticles of varying sizes, the authors 
also commented on the potentially important role of ambient 
ultraviolet light in providing antibacterial properties to ZnO. 
When comparable experiments were performed in the dark, 
high concentrations of 5 mM of 8 nm ZnO nanoparticles 
resulted in only a slight inhibition of bacterial growth after 
10 hours. However, increased doses of ultraviolet light in 
addition to the ambient light of the laboratory did not enhance 
this antibacterial effect beyond ambient light conditions.
Reduced viability of S. aureus and E. coli was observed 
when the bacteria were exposed to ZnO nanoparticles 
of decreasing size. However, a concentration of 5 mM 
(407.04 µg/mL) was necessary to reduce viability of either 
bacteria species at 24 hours even with 40 nm diameter 
particles, the smallest diameter ZnO nanoparticle tested.11 
The two bacteria species tested were affected approximately 
equally by the presence of nanoparticles. Irregularity in 
cell membranes of bacteria exposed to ZnO nanoparticles 
was also noted. An increased antimicrobial effect of ZnO 
nanoparticles on E. coli was observed at the 18-hour time 
point as the particle diameter was reduced from 2 µm to 
45 nm to 12 nm, and this was attributed to the enhanced effect 
of the greater surface area to volume ratios and mechanical 
damage caused to the cells due to increased abrasiveness of 
the smaller nanoparticles.12
A study which investigated the antibacterial effects 
of zinc ions identified MIC of 1917 µg/mL, 9 µg/mL, 
and 39 µg/mL at 48 hours for Pseudomonas aeruginosa, 
S. aureus, and Candida albicans, respectively.13,14 Compared 
to P . aeruginosa, S. aureus was found to be far more sensitive 
to lower concentrations of zinc ions.
In a study developed to elucidate the mechanisms of the 
antibacterial effect of ZnO particles, production of hydrogen 
peroxide, a reactive oxygen species attributed to bacteri-
cidal activity, in solutions with a variety of ceramic powder 
chemistries was determined.15 ZnO produced the greatest 
amount of hydrogen peroxide and the antibacterial effect of 
ZnO powders was attributed to this phenomenon. Hydrogen 
peroxide production was not detected with other ceramic pow-
ders tested (such as magnesium oxide and calcium oxide).
Yet, the mechanism of the antibacterial activity of ZnO 
nanoparticles is complex and not fully understood. Zinc ions 
are known to inhibit multiple activities in the bacterial cell, 
such as glycolysis, transmembrane proton translocation, 
and acid tolerance.16 In contrast to the presence of ZnO 
nanoparticles, the presence of zinc ions is likely only able 
to inhibit bacteria proliferation (bacteriostatic), rather than 
killing bacteria (bactericidal). The production of reactive 
  oxygen species and the disruption of cell membranes 
(Figure 1) caused by ZnO nanoparticles may actually be 
  bactericidal. However, Dimkpa et al found that while the 
presence of ZnO nanoparticles resulted in a   dose-dependent 
increase in the presence of reactive oxygen species, 
this increase in reactive oxygen species resulted in only 
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Figure 1 Zinc oxide (ZnO) nanoparticles (A), Escherichia coli bacteria prior to exposure 
to ZnO nanoparticles (B), and E. coli bacteria after exposure to ZnO nanoparticles (C). 
Membrane irregularities were observed in bacteria exposed to ZnO nanoparticles. 
With kind permission from Springer Science+Business Media: Journal of Nanoparticle 
Research.  Investigation  into  the  antibacterial  behaviour  of  suspensions  of  ZnO 
nanoparticles (ZnO nanofluids). 9(3), 2007, page 483. Zhang L. Figure 2.8International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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minimal bactericidal activity to bacteria species Pseudomo-
nas chlororaphis O6.17 All considered, the bactericidal 
properties of ZnO depend on multifactorial antibacterial 
  mechanisms. For bacteria grown in suspension in vitro, 
literature   suggests that smaller   diameter particles are more 
effective at reducing bacteria activity than larger particles 
with identical chemistry.2,11,12
Silver
The historical use of silver as an antibacterial agent made the 
progression to silver nanoparticles a logical and compelling 
step. As a naturally antibacterial metal, a silver nanoparticle 
likely has multiple mechanisms of antibacterial activity.
Silver nanoparticles with an average diameter of 
21 nm were shown to inhibit the growth of Gram-negative 
bacteria species (E. coli, Vibrio cholerae, Salmonella 
typhi, and P . aeruginosa) on agar plates with nanoparticle 
concentrations at or above 75 µg/mL.18 The authors attributed 
the bactericidal effect of silver nanoparticles to a number 
of mechanisms. First, membrane permeability was thought 
to be effected. The presence of a large number of nanopar-
ticles inside the bacteria suggests that this is an important 
mechanism. Interaction of silver particles with bacteria 
membrane and intracellular proteins, particularly sulfur-
containing membrane proteins and phosphorus-containing 
DNA,   interferes with cell division and causes cell death. The 
authors also confirmed the presence of biocidal ionic silver 
released from nanoparticle surfaces. Upon exposure to ionic 
silver, bacteria DNA conglomeration defense mechanisms 
protect it from a toxic surrounding environment but this 
compromises bacteria replication ability. Thus, the responses 
to ionic silver and nanoparticles are different, but both are 
essential to a complete understanding of the antibacterial 
activity of silver nanoparticles.
In a study comparing the morphological features of Gram-
positive (S. aureus) and Gram-negative (E. coli) bacteria 
exposed to the same concentration of silver ions (10 µg/mL 
silver nitrate for 4–12 hours), both bacteria species exhibited 
condensation of DNA, cell membrane separation from the 
cell wall, and cell wall damage.19 These characteristics are 
indicative of distressed bacteria that are being damaged. 
Furthermore, silver ions were detected within the cytoplasm 
of each bacteria type. These observations further clarified 
the role of the metal ion component in the antibacterial 
mechanism of silver.
A study designed to compare antibacterial properties 
of silver nanostructures of different shapes concluded that 
truncated triangular silver nanoplates and nanospheres 
were more effective at reducing E. coli viability than   silver 
nanorods or ionic silver.20 Various volumes of   silver nano-
structures were added to agar plates plated with bacteria 
cell suspensions. Colony formation was almost completely 
inhibited when 1 µg of triangular silver nanoplates with a 
width of about 50 nm was added to the agar plate of 106 CFUs. 
To comparably reduce bacteria activity with spherical nano-
particles, 12.5 µg was needed. Dose-dependent inhibition 
of bacteria activity was observed for all shapes of silver 
nanostructures, with triangular silver nanoplates exhibit-
ing the greatest antibacterial activity at low doses. The 
process of producing nanoplates may have resulted in the 
addition of a positive charge to the particle surface that 
enhanced electrostatic interactions between particles and 
cells. This, along with the increased number of active facets 
on a   triangular-shaped particle, was the explanation offered 
for the superior antibacterial activity of triangular particles, 
but the antibacterial activity of all silver nanostructures was 
  attributed to silver ion interference with cell membrane 
integrity, the respiratory chain, and DNA replication.
To determine the ability of silver nanoparticle con-
centrations to reduce bacteria growth on agar plates, 
silver nanoparticles with an average diameter of 12 nm 
were incorporated into agar plates at concentrations of 
10–100 µg/mL.3 E. coli was added to the plates at population 
densities of 105 CFUs. After 24 hours of growth, CFU 
populations on 10 µg/mL plates were 70% lower than on 
control plates which did not contain silver nanoparticles. 
A concentration-dependent inhibition of bacteria growth was 
observed as silver nanoparticle concentrations increased. 
Concentrations above 50 µg/mL completely inhibited E. coli 
growth. A   separate experiment determined that for a fixed 
concentration of nanoparticles, the growth of low bacteria 
seeding densities was completely inhibited while higher 
seeding densities were not. However, these higher seeding 
densities were above and beyond cell densities relevant to 
infection. When grown in lysogeny broth medium suspen-
sion, growth curves were only slightly reduced at 10 µg/mL 
concentrations of nanoparticles and were reduced by about 
50% after 9 hours in the presence of 100 µg/mL. As nano-
particle concentrations increased, some delay in growth was 
observed. The authors attributed the antibacterial activity to 
the same phenomena discussed by authors of other previous 
  studies, including membrane interference (Figure 2). While 
the silver nanoparticles appeared to somehow attach to the 
cell wall of the bacteria, the interaction was likely lower than 
it would have been if the particles had a positive rather than 
a negative charge.International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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S. aureus and E. coli were exposed to silver nanoparticles 
(mean average diameter = 13.5 nm, zeta potential under experi-
mental conditions = −0.33 mV) by adding 20 µL of a silver nano-
particle solution (of concentrations ranging from 21.54 ng/L to 
3.56 µg/L) directly to the surface of agar plates inoculated with 
107 CFUs.21 The MIC for E. coli was estimated to be 0.356 µg/L. 
For S. aureus, MIC values were determined to be somewhere 
above 3.56 µg/L, the highest concentration used in this study. 
The MIC for E. coli was far lower than the results from other 
studies due to differences in experimental methods such as the 
application of silver nanoparticles directly to the agar surface 
rather than incorporated throughout the volume of the agar.
Copper
Conventional copper, like conventional silver, exhibits 
antibacterial properties. Copper nanoparticles (mean average 
diameter = 100 nm) added to agar plates reduced E. coli and 
B. subtilis survival by 90% at concentrations of 33.40 µg/mL 
and 28.20 µg/mL, respectively.22 The growth of both bacteria 
species was completely inhibited at nanoparticle concentra-
tions above 60 µg/mL. Incidentally, in order to evaluate the 
difference in antibacterial effect of different metals, slightly 
smaller (mean average diameter = 40 nm) silver nanopar-
ticles were also tested. Concentrations of silver nanopar-
ticles   necessary to reduce E. coli and B. subtilis survival by 
90% were 58.4 µg/mL and 32.12 µg/mL,   respectively, higher 
than the concentrations of copper required. The authors pro-
posed that the mechanism by which the copper nanoparticles 
reduced bacteria viability was related to protein inactivation 
via thiol interaction.
In another study that utilized a unique method of 
impregnating filter paper with nanoparticles and placing 
pieces of filter paper on inoculated agar plates, the MIC of 
copper nanoparticles (mean average diameter = 10 nm) was 
determined to be 140–280 µg/mL for E. coli, depending 
on the strain tested, and 140 µg/mL for S. aureus strains.23 
The MBC were 160–300 µg/mL for the E. coli strains and 
160 µg/mL for the S. aureus strains. B. subtilis was found 
to be most sensitive to copper nanoparticles with an MIC of 
20 µg/mL and an MBC of 40 µg/mL. The authors commented 
on the difficulty of separating the antibacterial effect of the 
copper ions released from the nanoparticle surfaces and 
the antibacterial effect of the nanoparticles themselves. 
A separate study first observed the antibacterial effect of 
copper nanoparticles and then eliminated that antibacterial 
activity with the addition of a copper ion-specific chelator, 
bathocuproine, to demonstrate the importance of the role of 
copper ions in the antibacterial mechanism.
Interestingly, in a study summarized above, the Gram-
positive bacteria species, S. aureus, was more sensitive to 
copper nanoparticles than the Gram-negative species, E. coli. 
Considering the presence of the thick peptidoglycan layer in 
Gram-positive species, the purpose of which is to provide 
an additional structural barrier to harmful elements in the 
environment, it is somewhat counter-intuitive and surprising 
that a Gram-positive species would be more vulnerable to the 
antibacterial effect of any variety of nanoparticle.
Iron oxide
Although conventional iron oxide is not considered anti-
bacterial, a few studies on its effect on bacteria have been 
conducted and inhibition of bacteria activity has been 
observed. For example, iron oxide nanoparticles (mean 
average diameter = 9 nm, zeta potential under experimental 
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Figure  2  Transmission  electron  microscope  images  of  silver  nanoparticles 
used (A). Scanning electron microscope image of Escherichia coli control group   
(B) and E. coli exposed to 50 µg/mL of silver nanoparticles in lysogeny broth 
medium  for  4  hours  (C).  Transmission  electron  microscope  image  of  E.  coli 
exposed to 50 µg/mL of silver nanoparticles in lysogeny broth medium for 1 hour 
at  low  magnification  (D)  and  high  magnification  (E).  Reprinted  from  Journal  of 
Colloid and Interface Science, 275(1). Sondi I, Salopek-Sondi B. Silver nanoparticles as 
antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. 
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conditions = −19.09 mV) in a chain-like structure with 
a length of 100–200 nm were shown to reduce S. aureus 
viability as illustrated by a decrease in the ratio of live to 
dead cells.24 At concentrations of 3 mg/mL, iron oxide 
nanoparticles were shown to reduce cell viability at 4, 12, 
and 24 hours compared to bacteria culture controls with-
out nanoparticles and compared to lower concentrations 
of nanoparticles. The antibacterial mechanism of iron oxide 
nanoparticles was thought to be related to the ability of 
nanoparticles to penetrate into the cell and generate reactive 
oxygen species. The negative zeta potential of the nanopar-
ticles, and minimal electrostatic interactions with negative 
bacteria surface charges, may explain why relatively high 
concentrations of nanoparticles were needed to produce an 
antibacterial effect.
As another example, iron oxide nanoparticles (mean 
average diameter = 8 nm) in Staphylococcus epidermidis 
suspensions reduced cell numbers at 12-, 24-, and 48-hour 
time points in a dose-dependent matter, according to   optical 
density readings.25 After 48 hours, a concentration of 
2 mg/mL reduced cell populations by about 65% compared 
to control groups with no nanoparticles. High concentrations 
of nanoparticles (100 µg/mL, 1 mg/mL, and 2 mg/mL) 
also increased the number of dead cells observed during a 
live/dead assay. Antibacterial activity was again attributed 
to increasing oxidative stress and bacteria membrane 
interference.
Iron oxides are of particular interest not only due to their 
inherent antibacterial properties, but also due to their super-
paramagnetic properties that could allow such particles to be 
directed inside the body with a magnetic field, possibly after 
coating with some type of antimicrobial agent.
Miscellaneous nanoparticle chemistries
The antibacterial properties of a variety of other nanoparticle 
chemistries have been studied, often as a control group 
for other nanoparticle chemistries hypothesized to exhibit 
a strong antibacterial effect. The survival rate of Gram-
negative E. coli was evaluated in the presence of spherical, 
small diameter (∼11 nm, zeta potential under experimental 
conditions = 120 mV) nanoparticles of aluminum oxide.26 
A live/dead assay determined that 10, 100, and 500 µg/mL of 
aluminum oxide nanoparticles in aqueous bacteria suspensions 
reduced E. coli viability to 65%, 30%, and 32% survival, 
respectively, after 24 hours. The viability of Cupriavidus 
metallidurans was not affected by the presence of aluminum 
oxide nanoparticles, however, nanoparticles were observed 
on the cell membranes and in the periplasmic space of both 
bacteria species. Furthermore, a dose-dependent presence of 
reactive oxygen species was detected in both bacteria species. 
The authors speculated that the positive zeta potential of the 
nanoparticles enhanced the interaction between particles and 
cell membranes, and allowed for nanoparticle penetration into 
the cell and subsequent reactive oxygen species generation 
due in part to the presence of aluminum ions. For E. coli, 
this interaction reduced viability. It was speculated that the 
survival of C. metallidurans may be due to the increased 
expression of membrane restoration elements that protect 
the bacteria.
In a different study, aluminum oxide nanoparticles 
(mean average diameter = 60 nm, zeta potential under 
experimental conditions = 30 mV) at a concentration of 
20 µg/mL in a   bacteria suspension of E. coli (zeta potential 
under experimental conditions = −7.2 mV), B. subtilis (zeta 
potential under experimental conditions = −41.3 mV), or 
P . fluorescens (zeta potential under experimental condi-
tions = −32.3) reduced cell viability to 64%, 43%, and 30% 
of controls, respectively, as determined by optical density 
measurements of cell suspensions.9 In contrast, micronscale 
aluminum oxide powder (diameter = 400–1000 nm) at the 
same concentration did not reduce the viability of any of 
the bacteria species. Bacteria flocculation was observed 
in the presence of nanoparticles and was attributed to the 
negatively-charged bacteria drawn in to the positively-
charged nanoparticles. A substantial amount of nanopar-
ticles were observed on the bacteria surfaces and may have 
interfered with cell membrane integrity.
A variety of titanium dioxide nanoparticles (mean average 
diameter = 12–707 nm, zeta potential under experimental 
conditions = −50–44 mV) were added to aqueous bacteria 
suspensions at concentrations of 10, 100, and 500 µg/mL 
and were tested for viability with a live/dead assay.26 Of all 
the various particle diameters and zeta potentials tested, the 
titanium dioxide particles that were ineffective at   reducing 
bacteria viability were either large (770 nm diameter) or 
had a negative zeta potential. Small diameter nanopar-
ticles of approximately the same size exhibited a greater 
antibacterial effect when the zeta potential was more   positive. 
After 24 hours, the viability of E. coli in the presence of 
10, 100, and 500 µg/mL of titanium dioxide nanoparticles 
with a diameter of 17 nm and a zeta potential of 12 mV 
was 100%, 65%, and 20%, respectively. The presence of 
all varieties of nanoparticles was observed at the surface of 
cell membranes, but only particles with a positive zeta poten-
tial were observed in the periplasmic space. This   suggests that 
zeta potential plays a significant role in a particle’s ability to International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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penetrate into cell bodies. The presence of reactive oxygen 
species was observed for all titanium dioxide nanoparticle 
types, even those which did not reduce bacteria viability. 
Therefore, the authors of the study concluded the interference 
with membrane integrity was the most significant contribut-
ing factor to the antibacterial mechanism.
Silicon  dioxide  nanoparticles  (mean  average 
  diameter = 20 nm, zeta potential under experimental 
conditions = 35 mV) in a cell suspension at a concentra-
tion of 20 µg/mL have been observed to reduce bacteria 
viability of E. coli (zeta potential under experimental condi-
tions = −7.2 mV), B. subtilis (zeta potential under experimen-
tal conditions = −41.3 mV), or P . fluorescens (zeta potential 
under experimental conditions = −32.3) after 24 hours to 
42%, 60%, and 30% of controls, respectively.9 Micronscale 
silicon dioxide powder did not reduce the viability of any of 
the bacteria species. Electrostatic interactions between nano-
particles and bacteria was believed to contribute to nanopar-
ticle binding to cell membranes, membrane interference, and 
reduced cell viability. The positively-charged nanoparticles 
interacted with negatively-charged bacteria cell surfaces to 
promote flocculation, a phenomenon not observed in the 
presence of micronscale particles with matching chemistry 
and charge.
In addition to metal and metal oxide nanoparticles, 
naturally-occurring polymer varieties including chitosan 
have been investigated for their antibacterial properties. 
An in vitro study which investigated the antibacterial 
effects of chitosan nanoparticles (mean diameter = 40 nm, 
zeta potential under experimental conditions = 51 mV) on 
planktonic   bacteria in water via an optical density method 
reported an MIC of 0.125 µg/mL and 0.25 µg/mL for E. coli 
and S. aureus, respectively.27 The MBC was 4 µg/mL and 
8 µg/mL for E. coli and S. aureus, respectively. In this study, 
MIC and MBC values were cut approximately in half when 
the chitosan nanoparticles were loaded with copper (which 
increased both particle diameter and zeta potential to 257 nm 
and 95 mV , respectively). Both chitosan nanoparticles and 
copper-loaded nanoparticles had a lower MIC and MBC 
than control groups exposed to doxycycline. The antibacte-
rial effect of the nanoparticles was attributed to induced cell 
agglomeration and disruption of cell membranes.
A separate study looked specifically at the zeta 
potential of submicron chitosan particles and its role in 
the agglomeration of bacteria.28 The particles synthesized 
with the greatest positive zeta potential (mean average 
diameter = 380 ± 57 nm, zeta potential under experimental 
conditions = 51.1 ± 2.2 mV) more effectively promoted 
agglomeration in E. coli (zeta potential under experimental 
conditions = −14.7 ± 1.3) cell suspensions than low zeta 
potential submicron chitosan particles (mean average 
diameter = 199 ± 9 nm, zeta potential under experimental 
conditions = 29.4 ± 4.6 mV). This suggests that, in terms of 
promoting bacteria agglomeration, zeta potential is the key 
factor. Chitosan-coated alginate particles with a negative 
zeta potential did not promote agglomeration of the E. coli. 
The degree of bacteria agglomeration in the presence of 
particles with a positive zeta potential was dependent on the 
concentration of chitosan particles.
A study investigating the antibacterial effect of purified 
single-wall carbon nanotubes (diameter ∼1 nm, length ∼1 µm) 
found that a number of factors governed the magnitude of the 
antibacterial effect.29 For E. coli, P . aeruginosa, B. subtilis, 
and S. aureus, the viability of a cell suspension of 106–107 
CFU/mL was reduced to about 65%, 72%, 45%, and 50%, 
respectively, in the presence of carbon nanotubes for 
2 hours at a concentration of 5 µg/mL. The addition of 0.1% 
Tween-20® (ICI Americas, Inc, Wilmington, DE), which 
dispersed the carbon nanotubes and prevented agglomeration, 
significantly increased the antibacterial effect on each bacte-
ria species. The rate at which the samples were shaken on an 
orbital shaker during incubation also affected the antibacterial 
activity. Independent of the presence of surfactants, E. coli 
and B. subtilis were killed more effectively during a shaking 
incubation compared to a stationary incubation. Furthermore, 
the antibacterial effect increased yet again when the rate of 
shaking was increased. To better understand the antibacterial 
effect of carbon nanotubes, surface stiffness of the bacteria 
species was measured with atomic force microscopy. The 
bacteria species most affected by carbon nanotubes, Gram-
positive S. aureus and B. subtilis, were found to be the less 
stiff bacteria species. The susceptibility of softer bacteria, 
the increased antibacterial effect of carbon nanotubes with 
higher kinetic energy, and the increased antibacterial effect 
of dispersed carbon nanotubes suggests that the antibacterial 
mechanism may relate to the ability of nanotubes to puncture 
cell membranes and disrupt cell activity in that manner.
Summary of mechanisms
Looking at these studies collectively, certain antibacterial 
mechanisms seem to be independent of particle chemistry. 
Small nanoparticles (#30 nm) appear to be the most capable 
of penetrating into bacteria cell bodies. Interference with 
cell membranes, and subsequent loss of cell viability, is 
attributed to nearly all varieties of nanoparticles, but particu-
larly those with a small diameter and positive zeta potential. International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2777
Antimicrobial applications of nanotechnology
The electrostatic interaction of nanoparticles with positive 
zeta potential and negatively-charged bacteria surfaces draws 
the particles to the bacteria and promotes penetration into 
the membrane. Reactive oxygen species generation is also 
a nearly universally described mechanism of nanoparticle 
antibacterial activity, though one study measured compa-
rable levels of reactive oxygen species even at low doses of 
nanoparticles that did not reduce cell viability.26 The physical 
presence of a nanoparticle most likely disrupted cell mem-
branes in a dose-dependent manner.
Observed antibacterial effects of ZnO nanoparticles 
are not entirely consistent, but, based primarily on its 
susceptibility to ionic zinc, it appears that Gram-positive 
bacteria may be more susceptible to the reduction in viability 
than Gram-negative bacteria. Silver nanoparticles, however, 
were shown to be more effective at reducing viability of 
Gram-negative bacteria in at least one comparison study.21 
While ZnO produces reactive oxygen species (particularly in 
the presence of ultraviolet light) that interfere with cell func-
tions, silver ions disrupt DNA replication and cell division. 
Both particle chemistries also appear to compromise bacteria 
membrane integrity due to physical interactions.
A strongly positive zeta potential of a nanoparticle 
promotes nanoparticle interactions with cell membranes, 
membrane disruption, bacteria flocculation, and a   reduction 
in viability. Zeta potential, along with particle size and 
chemistry, is a highly relevant parameter controlling anti-
microbial effects. Considering previous studies as a whole, 
one can speculate that a very smaller diameter (,30 nm) 
nanoparticle of silver or ZnO that has been prepared to 
exhibit a positive surface charge will be the most effective 
to reducing bacteria viability.
Antibacterial nanoparticles  
and eukaryotic cells
The potential in vivo use of nanoparticles as an antibacterial 
agent is dependent on cytotoxicity to eukaryotic cells. In 
short, the concentrations of nanoparticles needed to kill 
  bacteria cannot exceed concentrations which would substan-
tially compromise functions of eukaryotic cells. While all 
varieties of nanoparticles could potentially exhibit cytotoxic 
properties, the summary presented here will be limited to 
only ZnO and silver nanoparticle varieties.
To investigate the cytotoxicity of ZnO nanoparticles on 
a model neural cell,30 3 × 104 mouse neuroblastoma 2A cells 
were first added to 96-well plates and incubated for 24 hours. 
ZnO nanoparticles (mean average diameter = 70 nm) were 
then added to the cell culture media at concentrations of 
10, 25, 50, and 100 µg/mL. After 12 hours of exposure to 
nanoparticles, an MTT viability assay was used to quantify 
the number of cells present. Concentrations of 10, 25, 50, 
and 100 µg/mL reduced cell viability to 90%, 80%, 55%, and 
10% of control groups, respectively. Another similar study 
investigated the viability of human astrocytoma U87 cells in 
the presence of ZnO nanoparticles (diameter #100 nm).31 
U87 cells were added to 96-well plates and exposed to 
varying concentrations of nanoparticles added to the cell cul-
ture media. At concentrations of 1 µg/mL or less, cell viabil-
ity was not affected. At a ZnO nanoparticle concentration of 
10 µg/mL cell viability was reduced to about 55% of control. 
Concentrations at or above 25 µg/mL reduced cell viability 
to less than 5%.
ZnO nanoparticles and their potential toxicity to lung 
epithelial cells was investigated in vitro by culturing 
A549 type II lung epithelial cells in the presence of 
40 µg/mL and 80 µg/mL ZnO nanoparticles (mean   average 
diameter = 71 nm, zeta potential under experimental 
conditions = 26.9 mV).32 After 18 hours, cells were rinsed, 
trypsinated, stained with trypan blue, and counted using a 
hemocytometer. Cell viability was reduced to 75% and 62% 
for 40 µg/mL and 80 µg/mL concentrations, respectively. The 
presence of reactive oxygen species was not significantly 
increased compared to control groups for either concentration 
of nanoparticles. While 40 µg/mL of nanoparticles did not 
significantly increase DNA damage, 80 µg/mL resulted in a 
small but significant increase in DNA damage and oxidative 
DNA lesions. Cytotoxicity and DNA damage was attributed 
in large part to the presence of ionic zinc.
The cytotoxicity of ZnO nanoparticles (mean average 
diameter = 19 nm) was tested on human mesothelioma 
MSTO-211H and rodent 3T3 fibroblast cells.33 After 
3 days, nanoparticle concentrations of 3.75 µg/mL did not 
significantly reduce viability, 7.5 µg/mL reduced viability of 
both cell types to about 75%, and concentrations at or above 
15 µg/mL killed nearly all cells present. The authors of the 
study partially attributes the toxicity of ZnO nanoparticles to 
the release of zinc ions and note that it is unclear whether ion 
release before or after nanoparticle uptake by the cells is most 
relevant. They also note that at nanoparticle concentrations of 
15 µg/mL, a critical amount of zinc was present to radically 
inhibit cell viability. Comparing to previous literature which 
established the cytotoxic threshold for ionic zinc, values of 
32 ppm34 and 10 ppm35 were found.
The toxicity of silver nanoparticles (mean average 
diameter = 10 nm) to human fibroblast cells was determined 
by adding nanoparticle-supplemented cell culture media to International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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a fixed number of cells and performing viability assays at 
24, 48, and 72 hours.36 Nanoparticle concentrations of 0, 25, 
50, 100, 200, 400 µg/mL reduced cell viability to 100%, 95%, 
90%, 80%, 75%, and 60%, respectively, compared to control 
groups at 24 hours. Additional reductions in viability were 
observed at 48 hours and 72 hours. At the 72-hour time point, 
nanoparticle concentrations at or above 200 µg/mL reduced 
viability to less than 50% of control. The authors attributed 
the dose-dependent toxicity of silver nanoparticles to the 
generation of reactive oxygen species and DNA damage 
which resulted in cell cycle arrest.
Collectively, these studies suggest that nanoparticle 
concentrations required to inhibit bacteria activity may have 
local cytotoxic effects. Concentrations of nanoparticles nec-
essary for the treatment of an infection must be limited to 
the proximity of the bacteria being treated. Relatively large 
doses of nanoparticles introduced to the infection site will 
become less concentrated as they dissipate throughout the 
body. Ideally, techniques to confine the nanoparticles to the 
site of infection can be developed.
Antibacterial nanorough surfaces
Surface chemistry and topography, including nanoscale 
topography, has been extensively studied in relation to 
eukaryotic cells, but is less understood in relation to bacteria. 
However, the limited number of studies so far has shown 
much promise.
The purpose of most antibacterial nanorough surfaces is to 
prevent bacteria adhesion and subsequent biofilm formation, 
the hallmark of infection. It is the colonization of a biomate-
rial surface with bacteria that is a great threat to the efficacy 
of the medical device. So while physical attraction to bacteria 
is a desirable property in antibacterial nanoparticles, it is an 
undesirable property for nanomaterial surfaces.   Positive zeta 
potential has been identified as an essential material property 
in nanoparticles, but may need to be avoided in antibacterial 
nanorough surfaces. The positive zeta potential, or surface 
charge, of a material surface may attract bacteria the same 
way that nanoparticles are attracted to the surface of bacteria. 
While nanoparticles may kill the bacteria, surfaces may be 
colonized more aggressively. Therefore, material surfaces 
should ideally have a negative surface charge in order to 
minimize the interaction with negatively-charged bacteria.
Some of the mechanisms thought to be most relevant 
to the antibacterial activity of nanoparticles may not be 
applicable to nanorough surfaces. Specifically, for particles 
that reduce bacteria viability primarily by penetrating into 
the bacteria cell body and compromising membrane integrity, 
a nanorough surface of comparable chemistry may not be 
strongly antibacterial. Other mechanisms related to the 
heightened antibacterial activity of nanomaterials, such as 
increased ion release, may be similarly heightened on nano-
rough surfaces as well due to increased functional surface 
area. However, other unique mechanisms may govern the 
antibacterial properties of materials which do not exhibit anti-
bacterial properties on conventional topography surfaces.
Micronscale roughness has been identified as an unde-
sirable property in biomaterial surfaces due to the bacteria’s 
ability to more easily establish the biofilm in grooves or pits 
on the material surface. However, the interaction between 
bacteria and nanorough surfaces, though not well understood, 
may theoretically reduce the adhesion of bacteria. Elements 
of the initial bacterial adhesion process are regulated by 
electrostatic interactions that may be enhanced when the cell 
wall of a bacterium can lay flush against a material surface. 
Roughness on the nanoscale may prevent close contact of the 
cell wall and material surface due to the relative rigidity of 
the cell wall. In contrast to a eukaryotic cell, which is very 
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Figure 3 Illustration comparing bacteria surface interactions with nanorough surfaces and conventional nanosmooth surfaces. Due to the high degree of roughness on 
nanomaterials, rigid bacteria cell membranes cannot lay flush against the material surface. This may inhibit the preliminary steps which lead to bacteria adhesion. As a result, 
bacteria activity on a nanomaterial surface may be reduced.International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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flexible, a bacteria cell wall may be unable to conform to the 
topography of a material with nanoscale surface features, 
inhibiting the early stages of bacteria adhesion (Figure 3).
One promising approach to antibacterial surfaces is to take 
a naturally antibacterial chemistry and produce a nano  rough 
surface with that material. One such study compared the bacte-
rial colonization of nanorough ZnO particle compacts to ZnO 
and titanium surfaces of conventional roughness.37 ZnO nano-
particles (mean average diameter = 23 nm) were pressed into 
compacts via a cold compaction technique to product surfaces 
with nanoroughness (Figure 4). For comparison, compacts of 
ZnO particles with a grain size of 4.1 µm were also produced. 
When S. epidermidis were cultured on the material surfaces, 
a decrease in CFUs was observed on micronrough ZnO 
compared to conventional titanium. A 35% further decrease 
in CFU/cm2 was observed on nanorough ZnO compared to 
micronrough ZnO. The antibacterial effect of zinc ions has 
been established, as has the enhanced release of metal ions from 
grain boundaries of nanomaterials. This explains one element 
of the mechanism of reduced bacteria activity on nanorough 
ZnO. Additionally, the nanoroughness of the surface may have 
played in a role in reducing bacteria adhesion.
Traditional biomaterial surfaces can also be functionalized 
with antimicrobial nanoparticles to produce a surface resistant 
to biofouling. In one such study, the polymer surface of a 
catheter was coated with silver nanoparticles (mean average 
  diameter = 10 nm).38 Multiple layers of nanoparticles were 
coated on the material surface to provide a layer with a thick-
ness of 80–120 nm (Figure 5). Pieces of the functionalized 
catheter were placed in a bacteria cell suspension for up to 
72 hours. The growth of bacteria in culture media and the 
viability on the surface of the material were tested. Growth 
of planktonic E. coli and S. aureus was reduced 100% at 
24, 48, and 72 hours. E. coli growth on the material surface 
was reduced 88%, 95%, and 83% at 24, 48, and 72 hours, 
  respectively. S. aureus growth on the material surface 
was reduced 93%, 95%, and 78% at 24, 48, and 72 hours, 
  respectively. Additional experiments confirmed that silver was 
slowly released from the material surface for at least 10 days, 
providing a sustained antimicrobial local   environment. These 
results are particularly exciting due to the high incidence of 
infection of venous and urinary catheters.
Figure 4 Atomic force microscopy images of particle compacts of microphase 
zinc oxide (ZnO) (A) and nanophase ZnO (B). Analysis indicated that compacts of 
nanophase ZnO had a 25% increase in surface area. Copyright © 2006, John Wiley 
and Sons. Adapted with permission from Colón G, Ward BC, Webster TJ. Increased 
osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO 
and TiO2. J Biomed Mater Res A. 2006;78(3):595–604.7
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Figure 5 X-ray electron microscopy image of silver nanoparticles (A) and a particle 
size  distribution  histogram  (B)  of  those  particles.  Higher  magnification  reveals 
polyhedral structure (C). Nondisruptive electron transmission microscopy reveals an 
80–120 nm coating of silver nanoparticles on the surfaces of a polymer catheter (D).International Journal of Nanomedicine 2012:7 submit your manuscript | www.dovepress.com
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Conclusion
Due to the increasing ineffectiveness of traditional antibiot-
ics, the nanoparticle has received increasing attention for 
its potential antimicrobial effects and applications. This 
makes the potential to treat infection with nanoparticles 
very intriguing. In vitro studies have identified nanoparticle 
concentrations which inhibit a variety of bacteria species. 
Nanoparticles of different materials and of different sizes 
vary in their effectiveness. The magnitude of the bactericidal/
bacteriostatic effect of the nanoparticle determines the dose 
required to effectively inhibit bacteria activity.
ZnO and silver nanoparticles, in particular, provide a sub-
stantial reduction in bacteria viability. A review of   previous 
studies reveals that particle diameter and surface charge are 
among the most relevant parameters which determine the 
effectiveness of an antimicrobial nanoparticle. In each study 
reviewed, the smallest nanoparticle tested generally had 
the strongest bactericidal effect. An increasingly positive 
surface charge (which results in the nanoparticle being 
drawn to the negatively-charged surface of the bacteria) is 
another property that enhanced bactericidal effects. While 
other nanoparticle chemistries, such as iron oxide, exhibit a 
lesser antibacterial effect, they may be functionalized with 
antimicrobial agents and directed with a magnetic field to 
provide custom, targeted infection treatments. Toxicity of 
nanoparticles to eukaryotic cells is a legitimate concern but 
may be addressed by targeting nanoparticles to a specific site 
and confining cytotoxic nanoparticle concentrations to the 
local environment of an infection.
Future studies will observe more physiologically   relevant 
modes of bacteria introduction to and interaction with nano-
materials. In vitro studies often use liquid   suspensions of 
bacteria in culture media that quickly develop into   bacteria 
populations which are far greater than physiologically   relevant 
values. To better understand the ability of nanoparticles and 
nanomaterial surfaces to prevent or treat infection, animal 
models of infection are necessary. In this way, the clinical 
potential of antimicrobial nanoparticles can more accurately 
be determined.
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